.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Teva
Boehringer Ingelheim
Mallinckrodt
Fish and Richardson
Medtronic
US Army
US Department of Justice
McKesson
Colorcon

Generated: December 14, 2017

DrugPatentWatch Database Preview

COLISTIMETHATE SODIUM Drug Profile

« Back to Dashboard

When do Colistimethate Sodium patents expire, and what generic alternatives are available?

Colistimethate Sodium is a drug marketed by Emcure Pharms Ltd, Fresenius Kabi Usa, Paddock Llc, Sagent Pharms, X Gen Pharms, and Xellia Pharms Aps. and is included in six NDAs.

The generic ingredient in COLISTIMETHATE SODIUM is colistimethate sodium. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the colistimethate sodium profile page.

Summary for COLISTIMETHATE SODIUM

Drug patent expirations by year for COLISTIMETHATE SODIUM

Pharmacology for COLISTIMETHATE SODIUM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms LtdCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION202359-001Sep 28, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sagent PharmsCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION201365-001Feb 19, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION065364-001Apr 17, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Paddock LlcCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION065177-001Mar 19, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Xellia Pharms ApsCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION205356-001May 29, 2015APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
X Gen PharmsCOLISTIMETHATE SODIUMcolistimethate sodiumINJECTABLE;INJECTION064216-001Feb 26, 1999APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Covington
Daiichi Sankyo
US Army
Cantor Fitzgerald
Cipla
Medtronic
Fuji
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot